Overview

Observational Study of SifrolĀ® in Patients With Primary Restless Legs Syndrome (RLS)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate treatment effect of pramipexole on RLS severity as measured by IRLS, CGI-I and RLS-6 and to evaluate the time needed to reach maintenance dose of Pramipexole (PPX)
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Pramipexole